Trulicity ® (dulaglutide) injection

0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mL

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

TRULICITY® (dulaglutide): QTC Interval

At supratherapeutic doses (4 and 7 mg), dulaglutide does not prolong QTc.

Detailed Information

The effect of dulaglutide on cardiac repolarization was thoroughly tested in a QTc study and found that at supratherapeutic doses, dulaglutide 4 mg and dulaglutide 7 mg did not prolong QTc.1

Enclosed Prescribing Information

TRULICITY® (dulaglutide) injection, for subcutaneous use, Lilly

Reference

1. Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

Glossary

QTc = corrected QT interval 

Date of Last Review: January 03, 2020

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Ask us a question Chat with us

Submit a Request

Visit Us @LillyMedical